Botox for Chronic Migraine: Medical Evaluation and Side Effects
OnabotulinumtoxinA (Botox) is effective only for chronic migraine (≥15 headache days/month for ≥3 months), not episodic migraine, and while numbness is not a recognized side effect of Botox, muscle weakness and ptosis can occur and typically resolve within 3-4 months as the medication wears off 1.
Critical Distinction: Chronic vs. Episodic Migraine
Before considering Botox, you must first establish whether the patient has chronic migraine (≥15 headache days per month for at least 3 months, with headaches lasting ≥4 hours) versus episodic migraine. This distinction is crucial because:
- Botox is effective and should be offered for chronic migraine 1
- Botox is ineffective for episodic migraine and should NOT be offered 1
- Botox is ineffective for tension-type headache and should NOT be offered 1
The 2024 VA/DoD guidelines confirm that abobotulinumtoxinA can be used for chronic migraine prevention but explicitly not for episodic migraine 2.
Medical Conditions to Evaluate Before Treatment
Based on current evidence and clinical practice guidelines, evaluate for:
Contraindications and Precautions:
- Neuromuscular disorders (myasthenia gravis, Lambert-Eaton syndrome, amyotrophic lateral sclerosis) - these are absolute contraindications
- Infection at injection sites - defer treatment until resolved
- Pregnancy or breastfeeding - safety not established
- Allergy to botulinum toxin or albumin
- Coexisting conditions requiring multi-indication Botox use - while generally safe, cumulative dosing must be monitored 3
Prior Treatment Requirements:
European consensus recommends patients should have tried 2-3 other migraine prophylactics before initiating Botox 4. The 2024 VA/DoD guidelines list alternative preventive options including topiramate, valproate, CGRP monoclonal antibodies, and atogepant 2.
Medication Overuse:
- Ideally withdraw overused medications before starting Botox 4
- However, if withdrawal is not feasible, Botox can be initiated concurrently with or before withdrawal 4
Addressing the Numbness Concern
Numbness is NOT a recognized adverse effect of Botox for chronic migraine. The established side effects from clinical trials and real-world data include 3, 5:
Common Side Effects (occurring in clinical practice):
- Neck pain (6.6% of patients)
- Brow ptosis (eyelid drooping) - 2.2%
- Muscle weakness - particularly in facial muscles and trapezius
- Diplopia (double vision)
- Shoulder weakness
Duration of Effects:
You are correct that Botox effects typically wear off in 3-4 months (specifically, treatment is administered every 12 weeks per the PREEMPT protocol) 4. However, this timeline applies to both therapeutic effects AND side effects like muscle weakness or ptosis - not numbness.
Long-term Neuromuscular Changes:
Recent 2026 data shows that 75% of patients treated for ≥1 year experience neuromuscular side effects, with cumulative changes most pronounced in the trapezius muscle after 2-5 years of treatment 5. These include denervation changes on EMG in up to 60% of patients, but again, sensory symptoms like numbness are not part of this profile.
Clinical Pitfall
If a patient reports numbness after Botox treatment, do not attribute it to the Botox. Investigate alternative causes:
- Migraine itself can cause sensory symptoms (migraine with aura)
- Cervical spine pathology
- Peripheral neuropathy
- Other neurological conditions
Botulinum toxin causes motor effects (weakness, ptosis) by blocking acetylcholine release at the neuromuscular junction - it does not directly affect sensory nerve function.
Treatment Protocol
When appropriate, administer according to the PREEMPT injection protocol: 155-195 units to 31-39 sites every 12 weeks 4. Define non-responders as those with <30% reduction in headache days per month, though also consider headache intensity, disability, and patient preferences 4. Stop treatment if no response after 2-3 treatment cycles 4.